Beyond PRP: Unlocking the Power of Pure PDGF with Dr. Sam Lynch of Ariessence
Join us for a virtual chairside chat exploring the next evolution in regenerative aesthetics: Pure PDGF (Platelet-Derived Growth Factor). Hosted by Moxie, this exclusive session features Dr. Sam Lynch, CEO of Ariessence, the company pioneering this novel advancement.
You’ll walk away with:
- A crystal-clear understanding of how Pure PDGF compares to PRP and exosomes
- Clinical insights from one of the earliest adopters of the technology
- Proven ways medspas are already leveraging Pure PDGF for superior patient outcomes and business growth
Whether you’re a practice currently supported by Moxie or simply exploring what’s next for your aesthetic business, this conversation will be both inspiring and actionable.
Featured Experts
Dr. Sam Lynch is a biotech pioneer with a passion for transforming clinical breakthroughs into accessible, practice-ready solutions. As the CEO of Ariessence, he leads the development of Pure PDGF, a next-generation regenerative technology rooted in decades of tissue engineering research. Prior to founding Ariessence, Dr. Lynch was the founding CEO of BioMimetic Therapeutics, where he led the development of the first FDA-approved PDGF drug for bone and periodontal regeneration. With a unique ability to bridge science, business, and patient care, Dr. Lynch is ushering in a new era of innovation for aesthetic and wellness providers.
Reserve your spot now →
Seats are limited and this topic is generating buzz—secure your place today to stay ahead of the curve in regenerative aesthetics.